Table 5 KEGG pathway analysis of DEGs expressed only in group A, not in other groups
Pathway ID | Pathway | DEGs with pathway annotation (295) | P-value |
|---|---|---|---|
ko05164 | Influenza A | 28(9.49%) | 5.35E-04 |
ko04145 | Phagosome | 22(7.46%) | 6.31E-04 |
ko05202 | Transcriptional misregulation in cancer | 22(7.46%) | 4.04E-04 |
ko05133 | Pertussis | 16(5.42%) | 2.83E-03 |
ko04668 | TNF signaling pathway | 15(5.08%) | 9.31E-05 |
ko04380 | Osteoclast differentiation | 15(5.08%) | 2.81E-03 |
ko05145 | Toxoplasmosis | 14(4.75%) | 2.22E-03 |
ko04640 | Hematopoietic cell lineage | 14(4.75%) | 1.00E-04 |
ko05222 | Small cell lung cancer | 13(4.41%) | 6.04E-04 |
ko05322 | Systemic lupus erythematosus | 12(4.07%) | 1.21E-03 |
ko05150 | Staphylococcus aureus infection | 11(3.73%) | 5.12E-04 |
ko04657 | IL-17 signaling pathway | 11(3.73%) | 3.98E-04 |
ko05130 | Pathogenic Escherichia coli infection | 8(2.71%) | 1.33E-03 |
ko05321 | Inflammatory bowel disease (IBD) | 8(2.71%) | 2.66E-03 |
ko05340 | Primary immunodeficiency | 7(2.37%) | 2.76E-05 |
ko01523 | Antifolate resistance | 6(2.03%) | 4.41E-04 |
ko00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 4(1.36%) | 1.23E-03 |